BTAI 8-K 2026-01-12

BioXcel Therapeutics, Inc. (BTAI) 8-K dated 2026-01-12 — accession 0001104659-26-002697. This URL is the filing, not the BTAI hub.

BioXcel Therapeutics, Inc. (BTAI) is a drug manufacturers - specialty & generic company listed on US.

BioXcel Therapeutics, Inc. filed a 8-K on 2026-01-12. Accession 0001104659-26-002697.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BTAI revenue for 2025-12-31 was $642.0K. Net income was -$69.9M. Revenue was down 71.7% from 2024-12-31 to 2025-12-31. BTAI currently screens at market cap $36.1M.

Not investment advice. The BTAI SEC hub lists recent forms. The stock page is the research view.